Trials / Terminated
TerminatedNCT01005459
Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE
Comparison of Spinal Tetracaine With Fentanyl and Epinephrine Versus Bupivacaine With Fentanyl and Epinephrine for Combined Spinal Epidural Labor Analgesia
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Wake Forest University · Academic / Other
- Sex
- Female
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesis is that spinal tetracaine with fentanyl and epinephrine used for CSE labor analgesia volume will last a significantly longer period of time that that of spinal bupivacaine with fentanyl. After informed consent is obtained for the study, subjects meeting criteria when analgesia is requested will be randomized to receive a combined spinal-epidural containing either tetracaine 2 mg with fentanyl and epinephrine or bupivacaine 2 mg with fentanyl and epinephrine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tetracaine | Tetracaine 2mg will be combined with Fentanyl 20 mcg and Epinephrine 50 mcg to treat labor pain. |
| DRUG | Bupivacaine | Bupivacaine 2 mg combined with fentanyl 20 mcg and Epinephrine 50 mcg will be used to treat labor pain. |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2011-12-12
- Completion
- 2011-12-12
- First posted
- 2009-11-02
- Last updated
- 2017-11-08
- Results posted
- 2017-07-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01005459. Inclusion in this directory is not an endorsement.